Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
France
In shortSanofi is profitable, generates cash and carries moderate debt, with revenue growing (+6.2% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 14.5% | 65/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 17.9% | 92/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 10.5% | 52/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 5.6% | 37/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.09× | 24/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.26× | 97/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 1.72× | 65/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 11.27× | 93/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | – | n/a |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 24.6% | 100/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 1.38× | 100/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 9.8% | 75/100 |
| Operating margin volatility | 3.9% | 74/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 0.5% | 19/100 |
|---|---|---|
| EPS growth, 3-year average | -1.5% | 18/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
European data comes from annual reports in ESEF format (since 2020). Industry and ticker are not provided by this source.
Annual figures as reported. Hover a bar or point for the exact value.
2 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
EUR millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 37,761 | 42,997 | 37,817 | 41,081 | 43,626 |
| Cost of revenue | 12,255 | 13,695 | 12,628 | 13,205 | 13,049 |
| Gross profit | 26,920 | 31,694 | 28,990 | 31,081 | 33,667 |
| Research & development | 5,692 | 6,706 | 6,507 | 7,394 | 7,842 |
| Selling, general & admin | 9,555 | 10,492 | 8,933 | 9,183 | 9,543 |
| Operating income | 8,126 | 10,656 | 6,960 | 7,252 | 6,344 |
| Interest expense | 368 | 440 | 1,293 | 1,073 | 563 |
| Income tax | 1,558 | 2,006 | 1,017 | 1,204 | 1,043 |
| Net income | 6,223 | 8,371 | 5,400 | 5,560 | 7,813 |
| Diluted EPS | €4.95 | €6.66 | €4.30 | €4.43 | €6.37 |
| Diluted shares (millions) | 1,258 | 1,257 | 1,256 | 1,256 | 1,226 |
2 older years available with the 10-year history. Essential plan, from €8.25/month →
Not computed: a required balance-sheet item is missing.
7/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: filings.xbrl.org (ESEF). Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Feb 17, 2026